Videos

Dr Schadendorf Discusses C.A.S.E. Study in CSCC; Current Treatment Changes

Dirk Schadendorf, MD, Department of Dermatology and the West German Cancer Center (WTZ) at the University Hospital Essen, discusses demographics, prior therapies and reasons for cemiplimab treatment for CSCC, and more. 

Stay in the know.
OncNet Newsletter